NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Honeycomb Biotechnologies

Honeycomb Biotechnologies

Private
Waltham, MassachusettsHealthcare & Life Scienceshttps://honeycomb.bio/

Last Round

Grant

Mar 1, 2023

Total Funding Raised

$1.88M

Company Overview

Honeycomb Biotechnologies is a biotechnology company that develops instrument-free single-cell analysis solutions for clinical and basic research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

single-cell genomicssingle-cell RNA sequencingscRNAseqsingle-cell analysisbioinformaticslab-on-a-chipsample stabilizationgenomic sequencinglife sciences toolsbiotech equipmentsingle-use devicebenchtop genomicsgene expression analysisclinical research toolssample collection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Honeycomb Biotechnologies Comps

Public and private peers based on sector, stage, and business model.

Honeycomb Biotechnologies comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Honeycomb Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2023
GrantMar 1, 2022
GrantMar 1, 2021
GrantSep 20, 2019

Key People

Founding team and executive leadership

James Flanigon

CEO, Co-Founder

Founding Team

Jim Flanigon

Chief Executive Officer

Executive Team

Honeycomb Biotechnologies Investors

Notable investors and investment history

Honeycomb Biotechnologies investors
InvestorRounds
NIH RADxGrant
Massachusetts Development Finance AgencyGrant

Honeycomb Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Honeycomb Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Honeycomb Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersWaltham, Massachusetts
Employee Range7
Year Founded2017
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.